Profound Medical Corp. (PROF) stock
PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.42−0.02 (-0.27%)
Close on Nov 13, 2026Market cap $271.07MP/E –Yield –
Profound Medical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Profound Medical's revenue for the twelve months ending Sep 30, 2026 was $23.63M, up 65.3% year over year. For fiscal 2025 it was $16.10M, up 50.7% from the year before. The highest annual figure on record is $16.10M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.10M | +50.7% |
| FY2024 | Dec 31, 2024 | $10.68M | +48.4% |
| FY2023 | Dec 31, 2023 | $7.20M | +7.8% |
| FY2022 | Dec 31, 2022 | $6.68M | -2.8% |
| FY2021 | Dec 31, 2021 | $6.87M | -5.9% |
| FY2020 | Dec 31, 2020 | $7.30M | +75.0% |
| FY2019 | Dec 31, 2019 | $4.17M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $9.83M | +85.9% |
| Q2 FY2026 | Jun 30, 2026 | $2.48M | +12.3% |
| Q1 FY2026 | Mar 31, 2026 | $5.34M | +103.6% |
| Q4 FY2025 | Dec 31, 2025 | $5.98M | +43.1% |
| Q3 FY2025 | Sep 30, 2025 | $5.29M | +86.8% |
| Q2 FY2025 | Jun 30, 2025 | $2.21M | -1.0% |
| Q1 FY2025 | Mar 31, 2025 | $2.62M | +82.1% |
| Q4 FY2024 | Dec 31, 2024 | $4.18M | – |
| Q3 FY2024 | Sep 30, 2024 | $2.83M | – |
| Q2 FY2024 | Jun 30, 2024 | $2.23M | – |
| Q1 FY2024 | Mar 31, 2024 | $1.44M | – |
See a number that looks wrong?